137 related articles for article (PubMed ID: 26854719)
1. Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.
Hallert E; Husberg M; Kalkan A; Bernfort L
Scand J Rheumatol; 2016 Oct; 45(5):371-8. PubMed ID: 26854719
[TBL] [Abstract][Full Text] [Related]
2. Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-up.
Husberg M; Bernfort L; Hallert E
Scand J Rheumatol; 2018 Sep; 47(5):378-383. PubMed ID: 29611446
[TBL] [Abstract][Full Text] [Related]
3. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.
Hallert E; Husberg M; Kalkan A; Skogh T; Bernfort L
Scand J Rheumatol; 2014; 43(3):177-83. PubMed ID: 24354438
[TBL] [Abstract][Full Text] [Related]
4. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
[TBL] [Abstract][Full Text] [Related]
7. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson JK; Johansson K; Askling J; Neovius M
Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
[TBL] [Abstract][Full Text] [Related]
8. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
[TBL] [Abstract][Full Text] [Related]
9. Evolution of cost structures in rheumatoid arthritis over the past decade.
Huscher D; Mittendorf T; von Hinüber U; Kötter I; Hoese G; Pfäfflin A; Bischoff S; Zink A;
Ann Rheum Dis; 2015 Apr; 74(4):738-45. PubMed ID: 24406543
[TBL] [Abstract][Full Text] [Related]
10. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
[TBL] [Abstract][Full Text] [Related]
11. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
Hu H; Luan L; Yang K; Li SC
Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
[TBL] [Abstract][Full Text] [Related]
12. Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.
Birnbaum HG; Pike C; Banerjee R; Waldman T; Cifaldi M
Pharmacoeconomics; 2012 Apr; 30(4):323-36. PubMed ID: 22379953
[TBL] [Abstract][Full Text] [Related]
13. Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'.
Hülsemann JL; Ruof J; Zeidler H; Mittendorf T
Rheumatol Int; 2006 Jun; 26(8):704-11. PubMed ID: 16261384
[TBL] [Abstract][Full Text] [Related]
14. The economic cost of low back pain in Sweden in 2001.
Ekman M; Johnell O; Lidgren L
Acta Orthop; 2005 Apr; 76(2):275-84. PubMed ID: 16097556
[TBL] [Abstract][Full Text] [Related]
15. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
16. Presence of anti-citrullinated protein antibodies and costs and disease activity in early rheumatoid arthritis - a 3-year follow-up.
Husberg M; Bernfort L; Hallert E
Scand J Rheumatol; 2020 Sep; 49(5):379-388. PubMed ID: 32686533
[No Abstract] [Full Text] [Related]
17. 28-Joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project.
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2011 Jul; 50(7):1259-67. PubMed ID: 21292734
[TBL] [Abstract][Full Text] [Related]
18. [Four years on a waiting lists for surgery--an expensive option. Millions in lost production while waiting for an orthopedic intervention].
Hansson T; Hansson E; Karlsson J
Lakartidningen; 2003 Apr; 100(16):1428-30, 1433-4. PubMed ID: 12756710
[TBL] [Abstract][Full Text] [Related]
19. Changes in sociodemographic characteristics at baseline in two Swedish cohorts of patients with early rheumatoid arthritis diagnosed 1996-98 and 2006-09.
Hallert E; Husberg M; Kalkan A; Rahmqvist M; Skogh T; Bernfort L
Scand J Rheumatol; 2015; 44(2):100-5. PubMed ID: 25352338
[TBL] [Abstract][Full Text] [Related]
20. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
